Note: An earlier version of this story stated the Scottish Medicines Consortium approved Vumerity for RRMS patients in that…
Articles by Marisa Wexler, MS
Doctors and nurses involved in the care of people with multiple sclerosis (MS) at a center in Scotland “highly”…
The majority of multiple sclerosis (MS) patients who stop taking Tysabri (natalizumab) before or when they become pregnant…
More than half of multiple sclerosis (MS) patients treated with self-injectable therapies — namely, glatiramer acetate, marketed as Copaxone,…
A novel algorithm that combines genetic, environmental, and clinical data could be useful for predicting whether people with a…
Multiple sclerosis (MS) is characterized by changes in methylation — a type of chemical modification in the DNA that…
Atara Biotherapeutics has reached an agreement with Fujifilm Diosynth Biotechnologies for the production of its cell therapy pipeline, including…
Vitamin D can influence the immune system’s tolerance to certain proteins by changing how DNA is packaged in specific immune…
Similarities between an Epstein-Barr virus (EBV) protein and a brain protein called GlialCAM may explain why EBV infection increases the risk…
A new imaging technique called magnetic resonance spectroscopic imaging, or MRSI, could be useful for diagnosing and monitoring multiple…
Differences in the physical architecture of the brain may explain why some people with multiple sclerosis (MS), but not…
Acthar Gel (repository corticotropin injection) may be useful for managing disease relapses in people with relapsing-remitting multiple sclerosis…
People with multiple sclerosis (MS) have high levels of toxic compounds made by gut bacteria in the fluid around…
A decision by the U.S. Court of Appeals for the Federal Circuit has upheld the validity of a patent for…
A new machine learning algorithm — designed to analyze healthcare records — could help in diagnosing multiple sclerosis (MS)…
Being a lifelong musician can help protect certain tracts of the brain’s white matter from damage during aging, potentially warding…
Multiple Sclerosis News Today brought you daily coverage of the latest scientific research, advances in treatment, and clinical trials related…
MS-STAT2, a clinical trial testing whether the cholesterol-lowering medication simvastatin might slow disability progression in secondary progressive multiple…
Certain treatments for multiple sclerosis (MS) — specifically, anti-CD20 antibody therapies and Gilenya (fingolimod) — are likely to…
There is minimal evidence that the expensive anti-inflammatory medication Acthar Gel (repository corticotropin injection) is more effective than inexpensive…
Leaders of the International Progressive MS Alliance have proposed a global research strategy to find better ways to care for…
Children and young adults who spend more time outdoors in the sunshine are less likely to develop multiple sclerosis…
An imaging technique called optical coherence tomography (OCT) could be useful for monitoring nervous system damage in people with…
The National MS Society has announced it is funding 13 new research projects that seek to better understand the…
Tecfidera (dimethyl fumarate) and Aubagio (teriflunomide) are the preferred disease-modifying treatments for managing relapsing-remitting multiple sclerosis (RRMS) in…
While older multiple sclerosis (MS) patients whose conditions are stable commonly stop using disease-modifying therapies (DMTs), a study…
A class of immune-suppressing medications called TNF-alpha inhibitors can reduce the efficacy of vaccines for COVID-19, according to a study…
Certain cell therapies that hold promise for treating autoimmune diseases like multiple sclerosis might work not because of the…
Immunic Therapeutics has enrolled the first participant in its Phase 3 ENSURE clinical trial program, which is testing the company’s…
Cholesterol made by neurons is crucial for repairing long-term damage to the myelin sheath, the fatty coating around nerve fibers…